BRD9 Antikörper (AA 168-217)
Kurzübersicht für BRD9 Antikörper (AA 168-217) (ABIN202100)
Target
Alle BRD9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 168-217
-
Spezifität
- Human BRD9
-
Homologie
- Percent identity by BLAST analysis: Human, Mouse, Rat, Dog, Horse (100%) Bovine, Rabbit, Guinea pig, Chicken (92%).
-
Aufreinigung
- Protein A purified
-
Immunogen
-
Synthetic peptide located between aa168-217 of human BRD9 (Q9H7R9, NP_076413). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey, Galago, Marmoset, Mouse, Rat, Dog, Horse, Opossum, Platypus (100%), Elephant, Bovine, Rabbit, Guinea pig, Turkey, Zebra finch, Chicken (92%), Lizard, Xenopus (85%).
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Approved: WB (2.5 μg/mL)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- After adding water, will consist of PBS buffer with 2 % sucrose
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- BRD9 (Bromodomain Containing 9 (BRD9))
-
Andere Bezeichnung
- BRD9
-
Hintergrund
-
Name/Gene ID: BRD9
Synonyms: BRD9, Bromodomain containing 9, PRO9856, Sarcoma antigen NY-SAR-29, LAVS3040 -
Gen-ID
- 65980
-
NCBI Accession
- NP_076413
Target
-